{"id":"recombinant-choriogonadotropin-alfa","safety":{"commonSideEffects":[{"rate":null,"effect":"Ovarian hyperstimulation syndrome (OHSS)"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Injection site reactions"},{"rate":null,"effect":"Abdominal pain/discomfort"},{"rate":null,"effect":"Nausea"}]},"_chembl":{"chemblId":"CHEMBL1201464","moleculeType":"Protein"},"_fixedAt":"2026-03-30T17:23:57.872638","_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"This recombinant glycoprotein hormone mimics endogenous hCG by binding to luteinizing hormone (LH) receptors on ovarian granulosa and theca cells. It induces the final maturation of oocytes and triggers ovulation approximately 34–36 hours after administration, making it essential for completing controlled ovarian hyperstimulation cycles in fertility treatment.","oneSentence":"Recombinant choriogonadotropin alfa (hCG) is a recombinant human chorionic gonadotropin that stimulates ovarian follicle development and triggers final oocyte maturation in assisted reproductive technology.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T00:52:14.233Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Final oocyte maturation and ovulation induction in assisted reproductive technology (ART) cycles"},{"name":"Controlled ovarian hyperstimulation in infertility treatment"}]},"_fixedFields":["modality→Biologic"],"trialDetails":[{"nctId":"NCT07425990","phase":"NA","title":"FET-LET-2x2: Clinical Pregnancy Rates After Frozen Embryo Transfer in Natural and Modified Natural Cycles","status":"NOT_YET_RECRUITING","sponsor":"University of Novi Sad","startDate":"2026-02","conditions":"Infertility Female, Frozen Embryo Transfer (FET)","enrollment":120},{"nctId":"NCT06440850","phase":"PHASE2","title":"Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2024-07-15","conditions":"Thyroid Gland Follicular Carcinoma, Thyroid Gland Oncocytic Carcinoma, Thyroid Gland Papillary Carcinoma","enrollment":21},{"nctId":"NCT06879002","phase":"","title":"Comparing IVF/ICSI Cycle Outcomes of Post Ovulation Ovarian Stimulation Protocol With Elonva Without GnRH Antagonist to Follicular Phase Day 2 Stimulation Fixed Day 5 Antagonist Protocol","status":"NOT_YET_RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2025-12-30","conditions":"Stimulation in the Ovary, IVF Outcome","enrollment":252},{"nctId":"NCT07128394","phase":"NA","title":"Extra Luteinizing Hormone Improve Embryo Quality in IVF Patients With Low LH During Long GnRH-Agonist Treatment","status":"RECRUITING","sponsor":"Nanjing University","startDate":"2024-02-01","conditions":"Infertility, Female, Luteinizing Hormone (LH)","enrollment":590},{"nctId":"NCT06572930","phase":"","title":"Serum FSH Monitoring for Identification of an Optimal Range During Ovarian Stimulation","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2024-12-16","conditions":"Ovarian Stimulation","enrollment":150},{"nctId":"NCT00702338","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05693 (P05713)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2008-05-15","conditions":"Pregnancy, Neonates","enrollment":1},{"nctId":"NCT00702520","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38833 (P05783)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-01","conditions":"Pregnancy, Neonates","enrollment":15},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT00702845","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Ensure)(P05690/MK-8962-001)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-12-28","conditions":"Infertility","enrollment":397},{"nctId":"NCT00697255","phase":"PHASE2","title":"A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recombinant FSH Can Induce Monofollicular Growth in Women With WHO Group II Anovulatory Infertility (P05693)","status":"TERMINATED","sponsor":"Organon and Co","startDate":"2007-05-15","conditions":"Ovulation Induction","enrollment":8},{"nctId":"NCT03846544","phase":"PHASE4","title":"Double Pick up in Poor Prognosis Women","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2019-10-01","conditions":"Fertility Disorders","enrollment":48},{"nctId":"NCT03564509","phase":"PHASE2","title":"A Trial to Investigate the Efficacy and Safety of FE 999302 as add-on Treatment to Follitropin Delta (REKOVELLE) in Women Undergoing Controlled Ovarian Stimulation.","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2018-05-14","conditions":"Controlled Ovarian Stimulation","enrollment":620},{"nctId":"NCT04189133","phase":"PHASE2","title":"Rec-LH PD and Safety Profile in Hypogonadotropic Hypogonadism Men","status":"UNKNOWN","sponsor":"Azienda Ospedaliero-Universitaria di Modena","startDate":"2022-01-19","conditions":"Acquired Hypogonadotropic Hypogonadism","enrollment":32},{"nctId":"NCT04446845","phase":"PHASE4","title":"Double Stimulation Followed by a Fresh Embryo Transfer","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2020-10-30","conditions":"Infertility","enrollment":120},{"nctId":"NCT05778331","phase":"","title":"The Difference Between POSEIDON Group 3 and Group 4 as Regards IVF","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-01-10","conditions":"Infertility, Female, IVF","enrollment":340},{"nctId":"NCT02402192","phase":"PHASE4","title":"Type of Gonadotropin and Embryo Kinetics of Development","status":"TERMINATED","sponsor":"IVI Madrid","startDate":"2015-04","conditions":"Infertility","enrollment":201},{"nctId":"NCT01599494","phase":"PHASE3","title":"An Efficacy and Safety Study of Corifollitropin Alfa (MK-8962) in Contrast to Recombinant FSH for Use in Controlled Ovarian Stimulation of Indian Women (P07056, Also Known as MK-8962-029)","status":"WITHDRAWN","sponsor":"Organon and Co","startDate":"2014-03","conditions":"Infertility","enrollment":""},{"nctId":"NCT01297465","phase":"PHASE3","title":"PERgoveriS In Stratified Treatment for Assisted Reproductive Technique","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2011-05-31","conditions":"Assisted Reproductive Techniques, Reproductive Technology, Assisted","enrollment":202},{"nctId":"NCT03876145","phase":"NA","title":"The Four Methods of Ovarian Stimulation in Patients With Polycystic Ovarian Syndrome","status":"COMPLETED","sponsor":"Royan Institute","startDate":"2016-11-12","conditions":"Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome","enrollment":120},{"nctId":"NCT01319695","phase":"PHASE1, PHASE2","title":"Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation","status":"COMPLETED","sponsor":"National and Kapodistrian University of Athens","startDate":"2011-01","conditions":"Infertility","enrollment":140},{"nctId":"NCT02145247","phase":"NA","title":"Ovarian Morphology and Theca Cell Androgen Production in Women With Polycystic Ovary Syndrome (PCOS)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2014-05","conditions":"Polycystic Ovary Syndrome","enrollment":39},{"nctId":"NCT02834117","phase":"PHASE4","title":"Natural Cycle Versus Stimulated Cycle Before Frozen Embryo Transfer","status":"COMPLETED","sponsor":"Dr Massin Nathalie","startDate":"2015-05","conditions":"Fertility","enrollment":124},{"nctId":"NCT02606500","phase":"PHASE4","title":"Efficacy of Corifollitropin Alfa in Obese Women in Terms of Clinical and Molecular Parameters of IVF Success","status":"COMPLETED","sponsor":"University Medical Centre Ljubljana","startDate":"2016-03","conditions":"Obesity","enrollment":70},{"nctId":"NCT01112358","phase":"PHASE2","title":"Lutropin Alfa in Women at Risk of Poor Response","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-12-07","conditions":"Ovarian Stimulation","enrollment":58},{"nctId":"NCT02607293","phase":"","title":"A Study to Explore Correlation Between Symptoms and Signs of Polycystic Ovarian Syndrome (PCOS) and Risk of Over-response to Ovarian Stimulation","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2015-12-31","conditions":"Polycystic Ovary Syndrome","enrollment":1064},{"nctId":"NCT00989781","phase":"NA","title":"Mechanisms of Increased Androgen Production Among Women With Polycystic Ovary Syndrome","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2009-09","conditions":"Polycystic Ovary Syndrome","enrollment":41},{"nctId":"NCT03480412","phase":"","title":"Second Step Protocol in Poor Ovarian Responder (POR)","status":"UNKNOWN","sponsor":"Università degli Studi 'G. d'Annunzio' Chieti e Pescara","startDate":"2017-09-01","conditions":"Infertility, Female, Premature Ovarian Failure, Fertility Disorders","enrollment":50},{"nctId":"NCT00249834","phase":"PHASE4","title":"Safety and Efficacy of Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing in Vitro Fertilization (IVF)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-09-22","conditions":"Infertility","enrollment":166},{"nctId":"NCT01110707","phase":"PHASE2","title":"A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Combined Treatment of Lutropin Alpha and Recombinant Human Luteinizing Hormone in the Middle of the Controlled Ovarian Stimulation Follicular Phase in Women With Reduced Ovarian Reserve","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-01-10","conditions":"Infertility, Ovulation Induction","enrollment":131},{"nctId":"NCT03118830","phase":"PHASE4","title":"Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSI","status":"COMPLETED","sponsor":"Cairo University","startDate":"2017-04-21","conditions":"Invitro Fertilization","enrollment":204},{"nctId":"NCT02047227","phase":"PHASE3","title":"Phase 3 Study to Evaluate the Efficacy and Safety of Pergoveris® in Assisted Reproductive Technology (ESPART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2014-01-31","conditions":"Infertility","enrollment":939},{"nctId":"NCT02118051","phase":"PHASE3","title":"Effect of Treatment With Corifollitropin Alpha in Vitro Fertilization in Patients With Poor Ovarian Response.","status":"COMPLETED","sponsor":"Instituto de Investigacion Sanitaria La Fe","startDate":"2013-09","conditions":"Infertility","enrollment":234},{"nctId":"NCT03071172","phase":"PHASE3","title":"Clinical Study of Recombinant Human Follitropin for Injection Assisted in COH Assisted IVF-ET","status":"UNKNOWN","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2017-03","conditions":"Ovarian Hyperstimulation Syndrome","enrollment":252},{"nctId":"NCT02825290","phase":"PHASE4","title":"Modified Luteal Support for Frozen-Thawed Embryo Transfer - A Prospective Study","status":"UNKNOWN","sponsor":"Sheba Medical Center","startDate":"2016-07","conditions":"Embryo Transfer, Luteal Support","enrollment":62},{"nctId":"NCT01871532","phase":"PHASE4","title":"Low-dose Gonal-f® in Ovulation Induction","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2013-07","conditions":"Infertility, Monofollicular Development","enrollment":24},{"nctId":"NCT02349945","phase":"PHASE2, PHASE3","title":"FSH Receptor Polymorphism p.N680S and Efficacy of FSH Therapy","status":"COMPLETED","sponsor":"Azienda USL Modena","startDate":"2011-01","conditions":"Male Infertility","enrollment":88},{"nctId":"NCT01653743","phase":"PHASE3","title":"Trial to Assess the Clinical Efficacy and Safety of MSJ-0011 in Inducing Ovulation in Anovulatory or Oligo-ovulatory Japanese Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-09","conditions":"Anovulation, Oligo-ovulation, Hypothalamic-pituitary Dysfunction","enrollment":81},{"nctId":"NCT01497197","phase":"PHASE3","title":"A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2012-05","conditions":"Infertility, Fertility, Follicle Stimulating Hormone Deficiency","enrollment":174},{"nctId":"NCT02442895","phase":"","title":"Biomarkers of Ovarian Reserve and Correlation With IVF Treatments","status":"COMPLETED","sponsor":"U.O.S. Procreazione Medicalmente Assistita e Congelamento Gameti","startDate":"2014-02","conditions":"Pregnancy, Ovarian","enrollment":236},{"nctId":"NCT02437032","phase":"PHASE4","title":"Gonadotropin Type in Ovarian Stimulation","status":"COMPLETED","sponsor":"IVI Madrid","startDate":"2009-04","conditions":"Infertility","enrollment":100},{"nctId":"NCT02140515","phase":"PHASE4","title":"Comparison of Assisted Reproductive Technology (ART) Outcomes Between Two Protocols of Induction of Ovulation in Patients With Hypogonadotropic Hypogonadism","status":"UNKNOWN","sponsor":"Royan Institute","startDate":"2012-11","conditions":"Infertility","enrollment":90},{"nctId":"NCT02244866","phase":"NA","title":"Efficacy of Pergoveris in Aged IVF Patients","status":"COMPLETED","sponsor":"Vietnam National University","startDate":"2012-10","conditions":"Infertility","enrollment":240},{"nctId":"NCT01100333","phase":"","title":"GONAL-f CONSORT (Consistency in r-hFSH Starting Doses for Individualised Treatment)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-04","conditions":"Infertility","enrollment":2552},{"nctId":"NCT01115725","phase":"","title":"A Study to Evaluate the Ease of Use, Local Tolerance, Safety and Effectiveness of Gonal-f® (Filled-by-mass in a Prefilled Pen)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2005-11","conditions":"Infertility","enrollment":76},{"nctId":"NCT01080729","phase":"","title":"An Observational Study to Compare the Dose of Gonal-fTM FbM Prescribed by the Doctor With the Recommendation of the Dose Calculator Consort and to Evaluate the Ease of Use of Pre-filled Pen of Gonal-fTM FbM Pen","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2009-02","conditions":"Multifollicular Stimulation","enrollment":25},{"nctId":"NCT00298025","phase":"PHASE4","title":"A Study to Compare the Safety and Efficacy of Cetrotide® 3 Milligram (mg) Versus Antagon™ in Women Undergoing Ovarian Stimulation","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2003-09","conditions":"Infertile Women Undergoing Assisted Reproductive Technology (ART)","enrollment":185},{"nctId":"NCT01225835","phase":"PHASE4","title":"Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)","status":"COMPLETED","sponsor":"Ferring Pharmaceuticals","startDate":"2010-10","conditions":"Infertility","enrollment":124},{"nctId":"NCT01079949","phase":"PHASE2","title":"A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Controlled Ovarian Stimulation (COS) in Advanced Reproductive Age","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-11","conditions":"Infertility, Ovulation Induction","enrollment":93},{"nctId":"NCT01075815","phase":"PHASE2","title":"A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced Reproductive Age","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-11","conditions":"Infertility, Ovulation Induction","enrollment":76},{"nctId":"NCT00505752","phase":"PHASE2","title":"Investigation of a Long-Acting Follicle Stimulating Hormone in Infertile Women Undergoing Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-01","conditions":"Infertility","enrollment":520},{"nctId":"NCT00553514","phase":"PHASE2","title":"AS900672-Enriched in Ovulation Induction","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2007-12","conditions":"Ovulation Induction","enrollment":71},{"nctId":"NCT01081626","phase":"PHASE4","title":"Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2009-03","conditions":"Ovulation Induction","enrollment":310},{"nctId":"NCT00829244","phase":"PHASE4","title":"CONSORT Randomized Controlled Trial in Assisted Reproductive Technology","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-08","conditions":"Infertility","enrollment":200},{"nctId":"NCT01185704","phase":"PHASE3","title":"Analysis of Two Therapeutic With Cetrotide® in Polycystic Ovarian (PCO) Women in Assisted Reproductive Technology (ART)","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-11","conditions":"Polycystic Ovarian Syndrome","enrollment":136},{"nctId":"NCT01735422","phase":"PHASE2","title":"A Study to Evaluate Safety and Efficacy of Recombinant Human Luteinizing Hormone (r-hLH) Compared With Urinary Human Chorionic Gonadotrophin (u-hCG) to Trigger Ovulation in Infertile Women","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"1999-12","conditions":"Infertility","enrollment":67},{"nctId":"NCT01210144","phase":"PHASE4","title":"EXpression PRofile Endometrium Samples Study","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2008-08","conditions":"In Vitro Fertilization","enrollment":27},{"nctId":"NCT01084265","phase":"PHASE3","title":"A Study Using Recombinant Human Luteinizing Hormone (r-hLH, Luveris®) in the Treatment of Chinese Women With Hypogonadotropic Hypogonadism","status":"COMPLETED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2004-02","conditions":"Hypogonadism","enrollment":31},{"nctId":"NCT00230815","phase":"PHASE3","title":"A Phase 3b Study to Evaluate Subject Satisfaction With Follitropin Alfa Injection in Oligoanovulatory Infertile Women Undergoing Ovulation Induction","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2004-07","conditions":"Infertility","enrollment":62},{"nctId":"NCT00328926","phase":"PHASE4","title":"Luveris® (Lutropin Alfa for Injection) in Women With Hypogonadotropic Hypogonadism (Luteinizing Hormone [LH] Less Than [<] 1.2 International Unit Per Liter [IU/L])","status":"TERMINATED","sponsor":"EMD Serono","startDate":"2006-03","conditions":"Hypogonadotropic Hypogonadism","enrollment":11},{"nctId":"NCT01152866","phase":"","title":"An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Technique (ART)","status":"COMPLETED","sponsor":"EMD Serono","startDate":"2003-12","conditions":"Ovulation Induction, Infertility","enrollment":3},{"nctId":"NCT01760278","phase":"PHASE4","title":"Assessment of Implantation Potential of Embryos by Time-lapse Technology","status":"UNKNOWN","sponsor":"Bloom IVF and Fertility Centre","startDate":"2012-12","conditions":"Embryo/Fetus Death, Blastocyst Disintegration, Aneuploidy","enrollment":200},{"nctId":"NCT00823121","phase":"PHASE1, PHASE2","title":"Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification","status":"UNKNOWN","sponsor":"Yazd Research & Clinical Center for Infertility","startDate":"2008-08","conditions":"In Vitro Fertilization","enrollment":500},{"nctId":"NCT00553293","phase":"PHASE4","title":"Nordic Luveris Study","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2003-08","conditions":"Infertility, In Vitro Fertilization","enrollment":526}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["OVITRELLE®."],"phase":"phase_3","status":"active","brandName":"Recombinant choriogonadotropin alfa","genericName":"Recombinant choriogonadotropin alfa","companyName":"Instituto de Investigacion Sanitaria La Fe","companyId":"instituto-de-investigacion-sanitaria-la-fe","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Recombinant choriogonadotropin alfa (hCG) is a recombinant human chorionic gonadotropin that stimulates ovarian follicle development and triggers final oocyte maturation in assisted reproductive technology. Used for Final oocyte maturation and ovulation induction in assisted reproductive technology (ART) cycles, Controlled ovarian hyperstimulation in infertility treatment.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}